Boehringer Ingelheim signs up Safwan as new Kuwait distributor

A leading player in Kuwait's health care business, Safwan representing a considerable number of well-known multinational principals.

It has been in business since 1967 and is recognized as a major supplier of pharmaceuticals, medical equipment and supplies, and laboratory products; from the health care sector to the Ministry of Health & other ministries, as well as public and private institutions.

In 2005, Safwan was placed as the first company in its category to be enlisted in the Kuwait Stock Exchange.

On the partnership, AAW Chairman and CEO Faisal Ali Al Mutawa, said: "We are honoured to be partnering with an international and world-renowned company like Boehringer Ingelheim. This partnership enables us to further develop the pharmaceutical sector in Kuwait and continue to provide the market with new medical and pharmaceutical products."

He was speaking at the signing ceremony which was also attended by top Safwan officials including COO Officer Dr Dina Younan, Pharma Manager Dr Tony Gerges, Regulatory PV and Tenders Manager Dr Absullah Al-Enezi and BI General Manager and Head of Human Pharma of GulfIP Mazen Bachir and National Sales Manager Hany El Kasaby.

Bachir said: "Through our partnership with Safwan Trading & Contracting we are strengthening BI’s position towards better serving our customers and all of Kuwait’s residents. This is also in line with the country’s national programme designed to ensure the continued provision of quality healthcare with the support of the private sector."

"We are very proud of our local teams who have worked relentlessly towards a smooth transition, laying the foundations for a bright future ahead of our organization. We are privileged to have the opportunity to support Kuwait towards delivering its social commitment to provide top-notch universal healthcare," he added.-TradeArabia News Service